CareDx, Inc (CDNA)
NASDAQ: CDNA · Real-Time Price · USD
18.97
-0.14 (-0.73%)
Jun 26, 2025, 12:44 PM - Market open
CareDx Revenue
CareDx had revenue of $84.69M in the quarter ending March 31, 2025, with 17.54% growth. This brings the company's revenue in the last twelve months to $346.42M, up 25.92% year-over-year. In the year 2024, CareDx had annual revenue of $333.79M with 19.07% growth.
Revenue (ttm)
$346.42M
Revenue Growth
+25.92%
P/S Ratio
2.96
Revenue / Employee
$532,955
Employees
650
Market Cap
1.06B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 333.79M | 53.46M | 19.07% |
Dec 31, 2023 | 280.32M | -41.47M | -12.89% |
Dec 31, 2022 | 321.79M | 25.40M | 8.57% |
Dec 31, 2021 | 296.40M | 104.20M | 54.22% |
Dec 31, 2020 | 192.19M | 65.13M | 51.25% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
CDNA News
- 12 days ago - CareDx: The Transplant Diagnostics Leader, But Challenges Will Increase On The Road Ahead - Seeking Alpha
- 22 days ago - CareDx Announces Repurchase of 5% of Outstanding Shares - Business Wire
- 6 weeks ago - CareDx to Participate in Upcoming Investor Conferences - Business Wire
- 2 months ago - CareDx, Inc (CDNA) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - CareDx Reports First Quarter 2025 Results - Business Wire
- 2 months ago - CareDx Announces New Data on AlloSure Lung Presented at 2025 International Society for Heart and Lung Transplantation Meeting - Business Wire
- 2 months ago - CareDx Announces Presentation of 60 Abstracts Including 19 Oral Presentations at the 2025 International Society for Heart and Lung Transplantation Meeting - Business Wire
- 2 months ago - CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - Business Wire